Cargando…
Reply to “Tachycardia, adverse effect, COVID-19 vaccine”
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817762/ https://www.ncbi.nlm.nih.gov/pubmed/36621254 http://dx.doi.org/10.1016/j.eimce.2022.05.012 |
| _version_ | 1784864822775513088 |
|---|---|
| author | Teresa Marco García, M. Lana, Álvaro Torres Berta Anta Agudo, M. de la Trinidad Rufino Delgado, M. |
| author_facet | Teresa Marco García, M. Lana, Álvaro Torres Berta Anta Agudo, M. de la Trinidad Rufino Delgado, M. |
| author_sort | Teresa Marco García, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9817762 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98177622023-01-06 Reply to “Tachycardia, adverse effect, COVID-19 vaccine” Teresa Marco García, M. Lana, Álvaro Torres Berta Anta Agudo, M. de la Trinidad Rufino Delgado, M. Enferm Infecc Microbiol Clin (Engl Ed) Letter to the Editor Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. 2023-01 2023-01-06 /pmc/articles/PMC9817762/ /pubmed/36621254 http://dx.doi.org/10.1016/j.eimce.2022.05.012 Text en © 2022 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Teresa Marco García, M. Lana, Álvaro Torres Berta Anta Agudo, M. de la Trinidad Rufino Delgado, M. Reply to “Tachycardia, adverse effect, COVID-19 vaccine” |
| title | Reply to “Tachycardia, adverse effect, COVID-19 vaccine” |
| title_full | Reply to “Tachycardia, adverse effect, COVID-19 vaccine” |
| title_fullStr | Reply to “Tachycardia, adverse effect, COVID-19 vaccine” |
| title_full_unstemmed | Reply to “Tachycardia, adverse effect, COVID-19 vaccine” |
| title_short | Reply to “Tachycardia, adverse effect, COVID-19 vaccine” |
| title_sort | reply to “tachycardia, adverse effect, covid-19 vaccine” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817762/ https://www.ncbi.nlm.nih.gov/pubmed/36621254 http://dx.doi.org/10.1016/j.eimce.2022.05.012 |
| work_keys_str_mv | AT teresamarcogarciam replytotachycardiaadverseeffectcovid19vaccine AT lanaalvarotorres replytotachycardiaadverseeffectcovid19vaccine AT bertaantaagudom replytotachycardiaadverseeffectcovid19vaccine AT delatrinidadrufinodelgadom replytotachycardiaadverseeffectcovid19vaccine |